Literature DB >> 14638973

Late onset Charcot-Marie-Tooth 2 syndrome caused by two novel mutations in the MPZ gene.

M Auer-Grumbach1, S Strasser-Fuchs, T Robl, C Windpassinger, K Wagner.   

Abstract

MPZ gene mutations cause demyelinating and axonal Charcot-Marie-Tooth (CMT) disease. Two novel MPZ mutations are reported in very late onset and progressive CMT syndrome. The N60H caused axonal CMT in a large family, whereas the I62M occurred in a single patient presenting with a primary axonal neuropathy. Previously, chronic polyradiculoneuritis was assumed in two patients. Molecular genetic testing and particularly screening for MPZ mutations in late onset neuropathies are important to differentiate acquired and inherited neuropathies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638973     DOI: 10.1212/01.wnl.0000094197.46109.75

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

Review 1.  Inherited neuropathies: clinical overview and update.

Authors:  Christopher J Klein; Xiaohui Duan; Michael E Shy
Journal:  Muscle Nerve       Date:  2013-06-26       Impact factor: 3.217

2.  Rare Variants in MME, Encoding Metalloprotease Neprilysin, Are Linked to Late-Onset Autosomal-Dominant Axonal Polyneuropathies.

Authors:  Michaela Auer-Grumbach; Stefan Toegel; Maria Schabhüttl; Daniela Weinmann; Catharina Chiari; David L H Bennett; Christian Beetz; Dennis Klein; Peter M Andersen; Ilka Böhme; Regina Fink-Puches; Michael Gonzalez; Matthew B Harms; William Motley; Mary M Reilly; Wilfried Renner; Sabine Rudnik-Schöneborn; Beate Schlotter-Weigel; Andreas C Themistocleous; Jochen H Weishaupt; Albert C Ludolph; Thomas Wieland; Feifei Tao; Lisa Abreu; Reinhard Windhager; Manuela Zitzelsberger; Tim M Strom; Thomas Walther; Steven S Scherer; Stephan Züchner; Rudolf Martini; Jan Senderek
Journal:  Am J Hum Genet       Date:  2016-09-01       Impact factor: 11.025

Review 3.  Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease.

Authors:  D Pareyson; V Scaioli; M Laurà
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 4.  Molecular genetics of autosomal-dominant axonal Charcot-Marie-Tooth disease.

Authors:  Stephan Züchner; Jeffery M Vance
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

5.  Late onset axonal Charcot-Marie-Tooth phenotype caused by a novel myelin protein zero mutation.

Authors:  H M E Bienfait; C G Faber; F Baas; A A W M Gabreëls-Festen; J H T M Koelman; J E Hoogendijk; J J Verschuuren; J H J Wokke; M de Visser
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

6.  Whole-exome sequencing in patients with inherited neuropathies: outcome and challenges.

Authors:  Maria Schabhüttl; Thomas Wieland; Jan Senderek; Jonathan Baets; Vincent Timmerman; Peter De Jonghe; Mary M Reilly; Karl Stieglbauer; Eva Laich; Reinhard Windhager; Wolfgang Erwa; Slave Trajanoski; Tim M Strom; Michaela Auer-Grumbach
Journal:  J Neurol       Date:  2014-03-15       Impact factor: 4.849

Review 7.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

8.  A nonsense mutation in MME gene associates with autosomal recessive late-onset Charcot-Marie-Tooth disease.

Authors:  Zeinab Jamiri; Rana Khosravi; Mohammad Mehdi Heidari; Ebrahim Kiani; Javad Gharechahi
Journal:  Mol Genet Genomic Med       Date:  2022-02-25       Impact factor: 2.473

9.  Case Report: Early-Onset Charcot-Marie-Tooth 2N With Reversible White Matter Lesions Repeatedly Mimicked Stroke or Encephalitis.

Authors:  Huasheng Huang; Yu Zhang; Mingxiu Yang; Baorong Lian; Rui Guo; Liming Cao
Journal:  Front Pediatr       Date:  2022-07-13       Impact factor: 3.569

10.  The genetic landscape of axonal neuropathies in the middle-aged and elderly: Focus on MME.

Authors:  Jan Senderek; Petra Lassuthova; Dagmara Kabzińska; Lisa Abreu; Jonathan Baets; Christian Beetz; Geir J Braathen; David Brenner; Joline Dalton; Lois Dankwa; Tine Deconinck; Peter De Jonghe; Bianca Dräger; Katja Eggermann; Melina Ellis; Carina Fischer; Tanya Stojkovic; David N Herrmann; Rita Horvath; Helle Høyer; Stephan Iglseder; Marina Kennerson; Katharina Kinslechner; Jennefer N Kohler; Ingo Kurth; Nigel G Laing; Phillipa J Lamont; Löscher Wolfgang N; Albert Ludolph; Wilson Marques; Garth Nicholson; Royston Ong; Susanne Petri; Gianina Ravenscroft; Adriana Rebelo; Giulia Ricci; Sabine Rudnik-Schöneborn; Anja Schirmacher; Beate Schlotter-Weigel; Ludger Schoels; Rebecca Schüle; Matthis Synofzik; Bruno Francou; Tim M Strom; Johannes Wagner; David Walk; Julia Wanschitz; Daniela Weinmann; Jochen Weishaupt; Manuela Wiessner; Reinhard Windhager; Peter Young; Stephan Züchner; Stefan Toegel; Pavel Seeman; Andrzej Kochański; Michaela Auer-Grumbach
Journal:  Neurology       Date:  2020-11-03       Impact factor: 9.910

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.